Medtronic is implementing a 9-month project that aims to develop its Patient Pathway Analytics and Innovation (PPAI) platform and establish the go-to-market strategy for the product.
PPAI aims to help healthcare service providers in low and middle-income countries (LMICs) to understand more accurately the unit cost of a patient pathway in an episode of care, i.e. the steps a patient goes through in being diagnosed and treated. Once this analysis has been completed, the PPAI platform is used to identify ways to reduce the cost of care delivery. These process improvements will enable healthcare resources to reach greater numbers of patients. The value proposition will be based on stakeholder research and feedback from Kenya, Nigeria, Pakistan and India.
Following the research phase, the project will support the detailed design of the PPAI application, development of a software prototype and user acceptance testing. In parallel, a market strategy will be developed to refine understanding of demand and willingness to pay among healthcare providers, and to identify priority markets. The final step will be to develop a business model to launch the product. If successful, Medtronic forecasts that, within 5 years of launch, it could reach 1 million low-income people who previously did not have access to healthcare services in LMICs.
The Business Partnership Fund is providing a grant of £250,000 to this project to develop the PPAI software.